Delivery Order SPE2DB20D1109-SPE2DB24FP07W
Award Date 4/29/24
Potential Completion Date 4/30/24
Potential Value $24K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET (30 count) to the Defense Logistics Agency (DLA). The $26,599.01 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 17, 2024 and was awarded on January 16, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, to the U.S. government. The $8,978.64 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. This contract is a child award under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through...
- This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S to the Defense Logistics Agency (DLA). The $4,644.48 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 24, 2025 with a completion date of March 25, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The $40,913.15 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 3, 2025, with a completion date of June 4, 2025. The contract is not set aside for any specific business designation. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $10,523.47, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and an ultimate completion date of December 5, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the...
- This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S to the Defense Logistics Agency (DLA), a defense agency. The $10,098.75 firm fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 5, 2025 with a completion date of June 6, 2025. The award is not associated with any set-aside designation, indicating open competition. As a significant vendor for the DLA,...
- This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The $27,693.37 firm fixed-price delivery order contract has a completion date of July 7, 2025 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 3, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- The federal contract award is for the pharmaceutical product BIKTARVY 50-200-25 MG TABLET, awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,524.28 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of November 5, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $78,507.79 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a specialty pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...
- This federal contract award is for the delivery of BIKTARVY 50-200-25 MG TABLET (30 count) to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,866.42 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, and does not have a set-aside designation. The contract has a performance period through September 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB24FP07WDelivery Order
This federal contract award is for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $23,765.86 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies for military healthcare programs. This contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and the contract is funded by the Defense agency.
Generated 5/16/25, 12:25 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.8k | 4/29/24 |